IP Verse

Antibodies With Modified Affinity To Fcrn That Promote Antigen Clearance - EP2552955

PATENT ANALYSIS

Patent Details

Grant Date
May 3, 2017
Company
CHUGAI SEIYAKU KABUSHIKI KAISHA
Oppositions

ABLYNX N.V.

ALEXION PHARMACEUTICALS, INC.

GLAXO GROUP LIMITED

MURPHY, COLM DAMIEN

SHIRE HUMAN GENETIC THERAPIES, INC.

TILLOTTS PHARMA AG

More patents of Chugai Seiyaku Kabushiki Kaisha

EP3296395

EP2679681

EP3320773

Want to monitor this patent?

Feel free to send us a message here and we will get back to you